Related Experiment Video
Updated: Jan 11, 2026

SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer
Published on: November 1, 2019
Unconventional protein secretion of La/SSB in liver cancer
Kento Konishi1, Yuta Mochimaru2, Ayano Matsumoto2
1Department of Biochemistry, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105-8461, Japan; Department of Surgery, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105-8461, Japan.
Abstract:
The La nucleoprotein/Sjögren syndrome type B antigen (La/SSB) is an RNA-binding factor in the nucleus that is associated with autoimmune diseases. In this study, we show that La/SSB is a biomarker for liver cancer. We detected full-length La/SSB in several liver cancer cell lines, but not in colorectal cancer cell lines. Importantly, serological analysis using a hepatocellular carcinoma (HCC) mouse model and human samples demonstrated that extracellular detection of La/SSB is specific for HCC. Furthermore, we found that the addition of exogenous La/SSB extract induces extracellular signal-regulated kinase (ERK) activation, which leads to accelerated cell growth. This study suggests that the La/SSB is a novel biomarker for HCC, and in the microenvironment, it may act as a growth factor in the progression of liver cancer.

